Similar articles for PMID: 30510853

Year	Number of Results
1991	1
1994	1
1996	2
1998	1
2000	2
2001	1
2002	4
2003	1
2004	4
2005	5
2006	6
2007	4
2008	4
2009	1
2010	3
2011	2
2013	2
2014	5
2015	4
2016	2
2017	9
2018	11
2019	4
2020	3
2022	1
2023	1
2024	0

1

Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma.

Ohara K, Ohkuri T, Kumai T, Nagato T, Nozaki Y, Ishibashi K, Kosaka A, Nagata M, Harabuchi S, Ohara M, Oikawa K, Aoki N, Harabuchi Y, Celis E, Kobayashi H. Ohara K, et al. Oncoimmunology. 2018 Aug 1;7(9):e1466771. doi: 10.1080/2162402X.2018.1466771. eCollection 2018. Oncoimmunology. 2018. PMID: 30510853 Free PMC article.

2

PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.

Hirata-Nozaki Y, Ohkuri T, Ohara K, Kumai T, Nagata M, Harabuchi S, Kosaka A, Nagato T, Ishibashi K, Oikawa K, Aoki N, Ohara M, Harabuchi Y, Uno Y, Takei H, Celis E, Kobayashi H. Hirata-Nozaki Y, et al. J Transl Med. 2019 Jun 20;17(1):207. doi: 10.1186/s12967-019-1957-5. J Transl Med. 2019. PMID: 31221178 Free PMC article.

3

Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma.

Hayashi R, Nagato T, Kumai T, Ohara K, Ohara M, Ohkuri T, Hirata-Nozaki Y, Harabuchi S, Kosaka A, Nagata M, Yajima Y, Yasuda S, Oikawa K, Kono M, Kishibe K, Takahara M, Katada A, Hayashi T, Celis E, Harabuchi Y, Kobayashi H. Hayashi R, et al. Oncoimmunology. 2020 Dec 29;10(1):1856545. doi: 10.1080/2162402X.2020.1856545. Oncoimmunology. 2020. PMID: 33457076 Free PMC article.

4

p53 as an immunotherapeutic target in head and neck cancer.

Hoffmann TK, Bier H, Donnenberg AD, Whiteside TL, De Leo AB. Hoffmann TK, et al. Adv Otorhinolaryngol. 2005;62:151-60. doi: 10.1159/000082505. Adv Otorhinolaryngol. 2005. PMID: 15608425

5

Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma.

Kumai T, Ohkuri T, Nagato T, Matsuda Y, Oikawa K, Aoki N, Kimura S, Celis E, Harabuchi Y, Kobayashi H. Kumai T, et al. Sci Rep. 2015 Nov 5;5:16280. doi: 10.1038/srep16280. Sci Rep. 2015. PMID: 26538233 Free PMC article.

6

Cancer immunotherapy using novel tumor-associated antigenic peptides identified by genome-wide cDNA microarray analyses.

Nishimura Y, Tomita Y, Yuno A, Yoshitake Y, Shinohara M. Nishimura Y, et al. Cancer Sci. 2015 May;106(5):505-11. doi: 10.1111/cas.12650. Epub 2015 Apr 1. Cancer Sci. 2015. PMID: 25726868 Free PMC article. Review.

7

Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer.

Ohara M, Ohara K, Kumai T, Ohkuri T, Nagato T, Hirata-Nozaki Y, Kosaka A, Nagata M, Hayashi R, Harabuchi S, Yajima Y, Oikawa K, Harabuchi Y, Sumi Y, Furukawa H, Kobayashi H. Ohara M, et al. Cancer Immunol Immunother. 2020 Jun;69(6):989-999. doi: 10.1007/s00262-020-02524-9. Epub 2020 Feb 21. Cancer Immunol Immunother. 2020. PMID: 32086539

8

Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.

Sirianni N, Ha PK, Oelke M, Califano J, Gooding W, Westra W, Whiteside TL, Koch WM, Schneck JP, DeLeo A, Ferris RL. Sirianni N, et al. Clin Cancer Res. 2004 Oct 15;10(20):6929-37. doi: 10.1158/1078-0432.CCR-04-0672. Clin Cancer Res. 2004. PMID: 15501971

9

Frequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer.

Hoffmann TK, Donnenberg AD, Finkelstein SD, Donnenberg VS, Friebe-Hoffmann U, Myers EN, Appella E, DeLeo AB, Whiteside TL. Hoffmann TK, et al. Cancer Res. 2002 Jun 15;62(12):3521-9. Cancer Res. 2002. PMID: 12067999

10

c-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK/T cell lymphoma.

Kumai T, Matsuda Y, Ohkuri T, Oikawa K, Ishibashi K, Aoki N, Kimura S, Harabuchi Y, Celis E, Kobayashi H. Kumai T, et al. Oncoimmunology. 2015 Mar 6;4(2):e976077. doi: 10.4161/2162402X.2014.976077. eCollection 2015 Feb. Oncoimmunology. 2015. PMID: 25949874 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

76 results

Results by year